Journal logo

Rising Drug Development Drives Clinical Trial Logistics Market Demand

Clinical Trial Supply And Logistics market is growing at rapid pace due to increased global drug development activities and complexities in clinical research.

By Paxton TempletonPublished 7 months ago 3 min read
Clinical Trial Supply And Logistics Market - The Research Insights

The unprecedented growth in pharmaceutical and biotechnology R&D activities along with the rise in number of decentralized, multi-regional, and multinational clinical trials are driving the demand for highly specialized, reliable, and compliant Clinical Trial Supply And Logistics services.

Clinical Trial Supply And Logistics Market Size: 2025 to 2030

The market is estimated to reach USD 6.72 billion by 2030 from USD 4.58 billion in 2025, at a CAGR of 7.97%. The growth in clinical trials of vaccines, biologics, personalized medicines, and rare disease therapies is expected to create challenges for logistics service providers to deliver faster, safer, and more affordable solutions in all geographies.

Why Is Clinical Trial Supply And Logistics Important?

Clinical Trial Supply And Logistics is the planning, storage, distribution, and tracking of investigational drugs, medical devices, laboratory samples, and clinical trial supplies, including blood, biologics, foods, biomarkers, phlebotomy supplies, personal protective equipment (PPE), investigational products, healthy controls, and medical waste.

These shipments require a tightly controlled supply chain, which accounts for temperature sensitivity, time-critical delivery, regulatory compliance, and chain-of-custody tracking and documentation.

Biologics, cell and gene therapies, and other temperature-sensitive clinical trial materials are driving increased demand for advanced logistics solutions such as cold chain, real-time tracking, and digital inventory management systems.

Key Drivers for Market

✅ Rising Global Drug Development

Thousand of clinical trials, including Phase I to IV studies are initiated every year in different therapeutic areas such as oncology, immunology, cardiology, dermatology, and endocrinology, adding complexity to trial execution and management. Sponsors and contract research organizations (CROs) are seeking experienced logistics partners with a global footprint and regulatory expertise to handle shipments across countries.

✅ Increasing Adoption of Decentralized and Hybrid Clinical Trials

Decentralized clinical trials (DCTs), also known as direct-to-patient trials, that include direct-to-patient shipments and remote monitoring of patients, gained popularity during the pandemic and will continue to be a key model. This model is heavily dependent on specialized logistics to ship investigational drugs and supplies to the participants’ homes as and when required, offering convenience and adherence.

✅ Rising Demand for Cold Chain and Temperature-Controlled Logistics Services

Biologics, vaccines, and certain biopharmaceuticals require stringent cold chain (storage and transport at 2–8°C) and temperature-controlled logistics solutions, as even a minor temperature excursion can lead to loss of potency. Logistics providers are investing in temperature-controlled shipping containers, data loggers, and validated shipping lanes to ensure product safety during transit.

Moreover, the ultra-low temperature (-80°C) requirement for mRNA vaccines is also driving demand for temperature-controlled logistics.

✅ Focus on Regulatory Compliance and Quality Assurance

Clinical Trial Supply And Logistics must comply with Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) guidelines. Logistics providers must also be aware of the country-specific regulations, documentation, and customs clearance.

Market Segmentation

By Service: Logistics & distribution services, warehousing, packaging & labeling, comparator sourcing, and cold chain logistics services

By Phase: Phase I, II, III, and IV clinical trials

Phase III trials, also known as late-stage development, constitute the largest market share due to its complex and larger patient pool. Phase III trial logistics is multi-regional and highly complicated involving multiple CROs, ethics committees/institutional review boards (EC/IRB), and investigational new drug (IND) applications.

By End User: Pharmaceutical companies, biotech companies, CROs, and academic research institutions

Regional Analysis

North America is the dominant region in the global market due to the high concentration of clinical research, high pharmaceutical infrastructure, and well-established logistics and distribution network.

Europe is the second-largest market due to high investments in life science R&D, increased number of decentralized trials, and presence of large biopharma players.

Asia-Pacific is a rapidly growing market, with countries such as India, China, South Korea, and Singapore offering cost-effective trial sites, evolving clinical research infrastructure, and increasing research activities.

Latin America and Middle East & Africa are the emerging markets in the industry, as they are gradually getting involved in multinational clinical trials.

Top Key Players

Some of the major players in the Clinical Trial Supply And Logistics market are:

  • DHL Supply Chain & Global Forwarding
  • Marken (UPS company)
  • World Courier (AmerisourceBergen company)
  • Catalent Inc.
  • FedEx Express
  • Parexel International
  • Biocair

These companies provide end-to-end solutions in Clinical Trial Supply And Logistics, including temperature-controlled warehousing, regulatory consulting, packaging, labeling, and site-to-site distribution, along with advanced digital platforms to enhance visibility and traceability.

Future Outlook 2030: Technology-Driven, Patient-Focused Supply Chain

As clinical trials get more global, decentralized, hybrid, patient-centric, and digital, logistics providers will have to keep pace with the rapidly changing landscape. The future supply chain will be technology-driven and defined by real-time data, AI-powered demand forecasting, and blockchain-based provenance and visibility.

In the next five years, the traditional clinical trial supply chain model will be replaced by agile, scalable, and technology-enabled clinical logistics ecosystems that can support both centralized and decentralized trials effectively.

Unlock exclusive market data.

Request a sample report for detailed insights at https://www.theresearchinsights.com/request_sample?id=108

business

About the Creator

Paxton Templeton

I’m a storyteller at heart with a passion for turning data into compelling narratives. With a focus on industry trends, market insights, and growth statistics, I bring clarity to complexity

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.